02509 荃信生物－Ｂ
按盘价 
20.850 +0.750 (+3.731%) | 2023/12 - 末期 人民币() | 与去年末期 比较 | 2022/12 人民币() | 2021/12 人民币() |
非流动资产
| 投资物业 | 0 | -- | 0 | 0 | ||
| 物业、厂房、设备及其他 | 339,106,000 | -6.615% | 363,125,000 | 378,335,000 | ||
| 租賃土地 | 22,329,000 | -3.082% | 23,039,000 | 22,497,000 | ||
| 无形资产 | 2,347,000 | -23.100% | 3,052,000 | 376,000 | ||
| 联营公司及共同控制公司权益 | 0 | -- | 0 | 0 | ||
| 其他非流动资产 | 13,472,000 | 35.588% | 9,936,000 | 18,024,000 | ||
| 377,254,000 | -5.486% | 399,152,000 | 419,232,000 |
流动资产
| 存货 | 4,937,000 | -- | 0 | 0 | ||
| 现金及银行结存 | 216,300,000 | 1.506% | 213,090,000 | 218,055,000 | ||
| 其他流动资产 | 197,092,000 | -53.390% | 422,858,000 | 430,206,000 | ||
| 持作出售资产 | 0 | -- | 0 | 0 | ||
| 418,329,000 | -34.220% | 635,948,000 | 648,261,000 |
流动负债
| 其他流动负债 | 251,776,000 | 106.053% | 122,190,000 | 69,673,000 | ||
| 持作出售资产相关负债 | 0 | -- | 0 | 0 | ||
| 251,776,000 | 106.053% | 122,190,000 | 69,673,000 | |||
| 流动资产净值 | 166,553,000 | -67.581% | 513,758,000 | 578,588,000 | ||
| 资产总额减流动负债 | 543,807,000 | -40.431% | 912,910,000 | 997,820,000 |
非流动负债
| 242,857,000 | -3.435% | 251,497,000 | 293,654,000 |
资本及储备
| 股本 | 210,025,000 | 16.341% | 180,525,000 | 166,480,000 | ||
| 储备 | 84,739,000 | -81.626% | 461,190,000 | 503,871,000 | ||
| 其他 | 0 | -- | 0 | 0 | ||
| 股东资金 | 294,764,000 | -54.066% | 641,715,000 | 670,351,000 | ||
| 非控股权益 | 6,186,000 | -68.596% | 19,698,000 | 33,815,000 | ||
| 其他 | 0 | -- | 0 | 0 | ||
| 300,950,000 | -54.499% | 661,413,000 | 704,166,000 |
承担及或然负债
| 承担 | -- | -- | 3,325,000 | 6,694,000 | ||
| 或然负债 | -- | -- | 0 | 0 |
| 备注： | 实时报价更新时间为16/07/2024 18:00 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
| 股东应占溢利/(亏损) () | RMB -507,748,000 |
| 增长率 | 70.276% |
| 每股盈利/(亏损) | RMB -- |
| 每股账面资产净值 (¥) | RMB -- |